Hydromet

Hydromet

Hydromet Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

May be habit forming. Hydrocodone can produce drug dependence of the morphine type and, therefore, has the potential for being abused. Psychic dependence, physical dependence and tolerance may develop upon repeated administration of hydrocodone bitartrate and homatropine methylbromide, and it should be prescribed and administered with the same degree of caution appropriate to the use of other narcotic drugs (see DRUG ABUSE AND DEPENDENCE).

Respiratory Depression:

Hydrocodone produces dose-related respiratory depression by directly acting on brain stem respiratory centers. If respiratory depression occurs, it may be antagonized by the use of naloxone hydrochloride and other supportive measures when indicated.

Head Injury And Increased Intracranial Pressure:

The respiratory depression properties of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a pre-existing increase in intracranial pressure. Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries.

Acute Abdominal Conditions:

The administration of hydrocodone or other narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions.

Pediatric Use:

In young pediatric patients, as well as adults, the respiratory center is sensitive to the depressant action of narcotic cough suppressants in a dose-dependent manner. Benefit to risk ratio should be carefully considered especially in pediatric patients with respiratory embarrassment (e.g., croup).

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For the symptomatic relief of cough.

History

There is currently no drug history available for this drug.

Other Information

This product contains hydrocodone (dihydrocodeinone) bitartrate, a semisynthetic centrally acting narcotic antitussive. Homatropine methylbromide is included in a subtherapeutic amount to discourage deliberate overdosage. Each 5 mL (one teaspoonful) contains:

Hydrocodone Bitartrate ........................ 5 mg

Homatropine Methylbromide ............... 1.5 mg

The hydrocodone component is 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5), a fine white crystal or crystalline powder, which is derived from the opium alkaloid, thebaine, has a molecular weight of 494.490, and may be represented by the following structural formula:

9206060a-figure-01

Hydrocodone Bitartrate

Homatropine methylbromide is a 3α-hydroxy-8-methyl-1αH, 5αH-tropanium bromide mandelate; a white crystal or fine white crystalline powder, with a molecular weight of 370.28.

9206060a-figure-02

Homatropine Methylbromide

Inactive Ingredients: Artificial Cherry Flavor, Citric Acid, D&C Red #33, FD&C Blue #1, FD&C Red #40, Methylparaben, Propylene Glycol, Purified Water, Saccharin Sodium, Sodium Benzoate, Sodium Citrate, Sucrose.

Hydromet Manufacturers


  • Bryant Ranch Prepack
    Hydromet (Hydrocodone Bitartate And Homatropine Methylbromide) Syrup [Bryant Ranch Prepack]
  • Actavis Mid Atlantic Llc
    Hydromet (Hydrocodone Bitartrate And Homatropine Methylbromide) Syrup [Actavis Mid Atlantic Llc]

Login To Your Free Account